Acurx Pharmaceuticals, Inc.
ACXP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001736243
No open-market purchases or sales by Acurx Pharmaceuticals, Inc. insiders were filed in the last 90 days; 18 institutions reported holding it in 13F filings for Q2 2026, worth $185.5K in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Acurx Pharmaceuticals, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 24 | 32 | +8 |
| Shares | 3.50M | 2.61M | −888.9K (−25.4%) |
| Value | $1.36M | $1.33M | −$34.0K (−2.5%) |
New holders (9)
Institutions that held Acurx Pharmaceuticals, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Armistice Capital, LLC | 1,078,540 | $550.9K | 0.02% |
| Susquehanna International Group, LLP | 69,745 | $35.6K | 0.00% |
| O'Brien Greene & Co. Inc | 60,000 | $30.6K | 0.01% |
| Virtu Financial LLC | 55,126 | $28.0K | 0.00% |
| ACT Advisors, LLC. | 45,952 | $23.5K | 0.01% |
| XTX Topco Ltd | 37,685 | $19.2K | 0.00% |
| Jane Street Group, LLC | 28,024 | $14.3K | 0.00% |
| Wealthcare Advisory Partners LLC | 11,538 | $5.89K | 0.00% |
| Baader Bank INC | 16,394 | $5.17K | 0.00% |
Sold out (1)
Institutions that held Acurx Pharmaceuticals, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| JPMorgan Chase & Co | 29 | $11 |